This new book in Remedica s State of the Art series contains up-to-date, comprehensive reviews by an international group of lung cancer experts on key topics in lung cancer, including the most recent advances in molecular biology, biomarkers, and molecular targeted therapies. All physicians who encounter patients with lung cancer will find that Lung Cancer: State of the Art provides a timely update on current and future treatment options. The book will enable readers to understand which treatment options hold the best hope for maximizing the quality of life, survival, and ultimately, chance of cure in individual patients. Only by keeping abreast of the latest developments in this continually evolving field will clinicians be able to provide their patients with optimal care. Contents: 1) Epidemiology, etiologic, and early detection 2) Pathology and molecular pathogenesis 3) Locally advanced non-small cell lung cancer 4) Adjuvant chemotherapy 5) Treatment of advanced non-small cell lung cancer 6) Perspectives on targeted therapies for non-small cell lung cancer 7) Management of small cell lung cancer 8) The clinical use of biomarkers in lung cancer
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Fred R Hirsch, MD, PhD Professor of Medicine and Pathology University of Colorado Cancer Centre Aurora, CO, USA. Peter Harper, FRCP, MRCS Consultant Medical Oncologist Guy s Hospital, London, UK
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : Mispah books, Redhill, SURRE, Royaume-Uni
paperback. Etat : Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book. N° de réf. du vendeur ERICA82319057215606
Quantité disponible : 1 disponible(s)